...
首页> 外文期刊>BMC Public Health >Sub-national disparities in accessing anti-malarial drug treatment in eastern Indonesia
【24h】

Sub-national disparities in accessing anti-malarial drug treatment in eastern Indonesia

机译:在印度尼西亚东部进入抗疟疾药物治疗的亚民族差异

获取原文
           

摘要

Poor access to health care providers was among the contributing factors to less prompt and ineffective malaria treatment. This limitation could cause severe diseases in remote areas. This study examined the sub-national disparities and predictors in accessing anti-malarial drug treatment among adults in Eastern Indonesia. The study analyzed a subset of the 2018 National Basic Health Survey conducted in all 34 provinces in Indonesia. We extracted socio-demographic data of 4655 adult respondents diagnosed with malaria in the past 12?months in five provinces in Eastern Indonesia. The association between socio-demographic factors and the access to anti-malarial drug treatment was assessed using logistic regression. Over 20% of respondents diagnosed with malaria within last 12?months admitted that they did not receive anti-malarial drug treatment (range 12–29.9%). The proportion of untreated cases was 12.0% in East Nusa Tenggara, 29.9% in Maluku, 23.1% in North Maluku, 12.7% in West Papua, and 15.6% in Papua. The likelihood of receiving anti-malarial drug treatment was statistically lower in Maluku (adjusted OR?=?0.258; 95% CI 0.161–0.143) and North Maluku (adjusted OR?=?0.473; 95% CI 0.266–0.840) than those in Eastern Nusa Tenggara (reference). Urban respondents were less likely to receive malaria treatment than rural (adjusted OR?=?0.545; 95% CI 0.431–0.689). This study found that there were sub-national disparities in accessing anti-malarial drug treatment in Eastern Indonesia, with a high proportion of untreated malaria cases across the areas. Findings from this study could be used as baseline information to improve access to anti-malarial drug treatment and better target malaria intervention in Eastern Indonesia.
机译:较差的医疗保健提供者是较少促使和无效疟疾治疗的贡献因素之一。这种限制可能导致偏远地区的严重疾病。本研究审查了在印度尼西亚东部抗疟疾药物治疗的亚民族差异和预测因素。该研究分析了印度尼西亚所有34个省份的2018年国家基本健康调查的子集。我们提取了4655名成年受访者的社会人口统计数据,诊断为患有疟疾的疟疾12月12日在印度尼西亚东部的五个省份。使用Logistic回归评估社会人口因子与抗疟疾药物治疗的协会。超过12%的受访者患有疟疾的患者在过去12人内患有疟疾?几个月内承认他们没有接受抗疟疾药物治疗(范围12-29.9%)。未处理病例的比例为12.0%,在努沙腾加拉,Maluku 29.9%,北方Maluku 23.1%,西巴布亚12.7%,巴布亚人15.6%。接受抗疟疾药物治疗的可能性在maluku统计学上较低(调整或Δ= 0.258; 95%CI 0.161-0.143)和北部Maluku(调整或?= 0.473; 95%CI 0.266-0.840)东部努沙腾加拉(参考)。城市受访者不太可能接受疟疾治疗的疟疾治疗(调整或?= 0.545; 95%CI 0.431-0.689)。本研究发现,在印度尼西亚东部的抗疟疾药物治疗方面存在亚民族差异,在该地区的未经治疗的疟疾病例比例高比例。本研究的结果可用作基线信息,以改善对印度尼西亚东部的抗疟疾药物治疗和更好的目标疟疾干预。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号